Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mary Relling
Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Modified Forward Multiple Regression in High-Density Genome-Wide Association Studies for Complex Traits
Genetic Epidemiology
Epidemiology
Genetics
Related publications
Comprehensive Analysis ofUGT1APolymorphisms Predictive for Pharmacokinetics and Treatment Outcome in Patients With Non–Small-Cell Lung Cancer Treated With Irinotecan and Cisplatin
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Clinical Validity of New Genetic Biomarkers of Irinotecan Neutropenia: An Independent Replication Study
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
66 Clinical Validity of New Genetic Biomarkers of Irinotecan Neutropenia: An Independent Replication Study
European Journal of Cancer
Cancer Research
Oncology
Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive Analysis
CPT: Pharmacometrics and Systems Pharmacology
Modeling
Simulation
Cardiovascular Medicine
Pharmacology
Cardiology
Investigation of UGT1A1 Polymorphism and Pharmacokinetic Analysis on Irinotecan (CPT-11) and Its Metabolites for a Patient Who Developed Severe Neutropenia During Treatment With IFL Regimen
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
Safety and Pharmacokinetics of Intravenous Anidulafungin in Children With Neutropenia at High Risk for Invasive Fungal Infections
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Low Heritability in Pharmacokinetics of Talinolol: A Pharmacogenetic Twin Study on the Heritability of the Pharmacokinetics of Talinolol, a Putative Probe Drug of MDR1 and Other Membrane Transporters
Genome Medicine
Molecular Medicine
Genetics
Molecular Biology
Comprehensive Pharmacogenetic Profiling of the Epidermal Growth Factor Receptor Pathway for Biomarkers of Response To, and Toxicity From, Cetuximab
Journal of Medical Genetics
Genetics
Pharmacokinetics of Efavirenz When Co-Administered With Rifampin in TB/HIV Co-Infected Patients: Pharmacogenetic Effect ofCYP2B6Variation
Journal of Clinical Pharmacology
Pharmacology
